Zobrazeno 1 - 5
of 5
pro vyhledávání: '"DelGaudio NL"'
Autor:
Donaldson GP, Reis GL, Saad M, Wichmann C, Mamede I, Chen G, DelGaudio NL, Zhang D, Aydin B, Harrer CE, Castro TBR, Grivennikov S, Reis BS, Stadtmueller BM, Victora GD, Mucida D
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.
Autor:
Timson RC; Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, New York, USA., Khan A; Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, New York, USA., Uygur B; Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, New York, USA., Saad M; Laboratory of Mucosal Immunology, The Rockefeller University, New York, New York, USA., Yeh HW; Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, New York, USA., DelGaudio NL; Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, New York, USA., Weber R; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Alwaseem H; The Proteomics Resource Center, The Rockefeller University, New York, New York, USA., Gao J; The CRISPR & Genome Editing Center, The Rockefeller University, New York, New York, USA., Yang C; The CRISPR & Genome Editing Center, The Rockefeller University, New York, New York, USA., Birsoy K; Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, New York, USA. Electronic address: kbirsoy@rockefeller.edu.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Feb; Vol. 300 (2), pp. 105645. Date of Electronic Publication: 2024 Jan 11.
Autor:
Xiao W; Department of Pathology, Hematopathology Service.; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., Chan A; Department of Pathology, Hematopathology Service., Waarts MR; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., Mishra T; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., Liu Y; Department of Pathology, Hematopathology Service., Cai SF; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service.; Department of Medicine, Leukemia Service., Yao J; Department of Pathology, Molecular Diagnostic Laboratory., Gao Q; Department of Pathology, Hematopathology Service., Bowman RL; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., Koche RP; Center for Epigenetics Research., Csete IS; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., DelGaudio NL; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., Derkach A; Department of Epidemiology-Biostatistics., Baik J; Department of Pathology, Hematopathology Service., Yanis S; Department of Pathology, Hematopathology Service., Famulare CA; Center for Hematologic Malignancies, and., Patel M; Center for Hematologic Malignancies, and., Arcila ME; Department of Pathology, Hematopathology Service.; Department of Pathology, Molecular Diagnostic Laboratory., Stahl M; Department of Medicine, Leukemia Service., Rampal RK; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service.; Department of Medicine, Leukemia Service., Tallman MS; Department of Medicine, Leukemia Service., Zhang Y; Department of Pathology, Cytogenetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY., Dogan A; Department of Pathology, Hematopathology Service., Goldberg AD; Department of Medicine, Leukemia Service., Roshal M; Department of Pathology, Hematopathology Service., Levine RL; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service.; Department of Medicine, Leukemia Service.; Center for Epigenetics Research.; Center for Hematologic Malignancies, and.
Publikováno v:
Blood [Blood] 2021 Mar 11; Vol. 137 (10), pp. 1377-1391.
Autor:
Xiao W; Hematopathology Service, Department of Pathology.; Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program., Miles LA; Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program., Bowman RL; Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program., Durani V; Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program., Tian HS; Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program., DelGaudio NL; Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program., Mishra T; Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program., Zhu M; Diagnostic Molecular Pathology, Department of Pathology., Zhang Y; Cytogenetics Laboratory, Department of Pathology., Stump SE; Leukemia Service, Department of Pharmacy, and., Tallman MS; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Levine RL; Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program.; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Cai SF; Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program.; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Blood advances [Blood Adv] 2020 Dec 08; Vol. 4 (23), pp. 6034-6038.
Autor:
Cai SF; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Leukemia Service, Department of Medicine, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Chu SH; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Goldberg AD; Leukemia Service, Department of Medicine, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Parvin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York., Glass JL; Leukemia Service, Department of Medicine, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Stein EM; Leukemia Service, Department of Medicine, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Tallman MS; Leukemia Service, Department of Medicine, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Sen F; Hematopathology Diagnostic Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Famulare CA; Leukemia Service, Department of Medicine, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Cusan M; University Hospital, Ludwig Maximilian University Munich, Munich, Germany., Huang CH; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York., Chen CW; Department of Systems Biology, Beckman Research Institute, City of Hope, Duarte, California., Zou L; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York., Cordner KB; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., DelGaudio NL; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Durani V; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Kini M; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Rex M; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Tian HS; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Zuber J; Research Institute of Molecular Pathology (IMP), Vienna, Austria., Baslan T; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York., Lowe SW; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Howard Hughes Medical Institute, New York, New York., Rienhoff HY Jr; Imago Biosciences, Inc., San Francisco, California., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Levine RL; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. scott_armstrong@dfci.harvard.edu leviner@mskcc.org.; Leukemia Service, Department of Medicine, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. scott_armstrong@dfci.harvard.edu leviner@mskcc.org.
Publikováno v:
Cancer discovery [Cancer Discov] 2020 Oct; Vol. 10 (10), pp. 1500-1513. Date of Electronic Publication: 2020 Jun 30.